Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

The former Democrat-turned-independent Kennedy endorsed Trump after dropping an unaligned bid for the presidency. While a core part of his campaign was advocating for dubious health issues, he is not ...

Donald Trump promised in 2016 that he would open the JFK records, but he never finished. This time, though, he has survived an assassination attempt. | Opinion ...

J.K.Rowling has been bombarded with comments online for calling ... Comments overwhelmed Rowling’s X post. “You sound like ...

As Trump gears up to reenter the White House and bring RFK Jr. with him, Kennedy has signaled what exactly his role would ...

Vardis J. Vardinoyannis, a powerful and pivotal figure in Greek shipping and energy who survived a terrorist attack and ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

President-elect Donald J. Trump has indicated that he would support ending water fluoridation. Mayor Eric Adams was reticent ...

Now that the 2024 presidential election has come to its inevitable if protracted conclusion, can we turn the page? Donald ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

Former presidential candidate Robert F. Kennedy J, billionaire hedge fund manager John Paulson and investor Scott Bessent are also seen as possible cabinet officers in his administration. Meanwhile ...